Cardiac-specific overexpression of RhoA results in sinus and atrioventricular nodal dysfunction and contractile failure.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of Clinical Investigation

• Publication date

  1999-06-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI6842PMID 10377168PMCID PMC408391
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The small GTP-binding protein RhoA regulates a delayed rectifier potassium channel.

  1998cited by this paper
• Decompensation of Pressure-Overload Hypertrophy in Gαq-Overexpressing Mice

  1998cited by this paper
• Enhanced Galphaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure.

  1998cited by this paper
• Decompensation of pressure-overload hypertrophy in G alpha q-overexpressing mice.

  1998cited by this paper
• The Low Molecular Weight GTPase Rho Regulates Myofibril Formation and Organization in Neonatal Rat Ventricular Myocytes

  1998cited by this paper
• Transient cardiac expression of constitutively active Galphaq leads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathways.

  1998cited by this paper
• Ras and rho are required for galphaq-induced hypertrophic gene expression in neonatal rat cardiac myocytes.

  1998cited by this paper
• Selective Requirement of Myosin Light Chain 2v in Embryonic Heart Function*

  1998cited by this paper
• Hypertrophy, pathology, and molecular markers of cardiac pathogenesis.

  1998cited by this paper
• Rho GTPases*

  1998cited by this paper
• Angiotensin II activates RhoA in cardiac myocytes: a critical role of RhoA in angiotensin II-induced premyofibril formation.

  1998cited by this paper
• Transgenic Gαq overexpression induces cardiac contractile failure in mice

  1997influential reference
• MAP kinase‐ and Rho‐dependent signals interact to regulate gene expression but not actin morphology in cardiac muscle cells

  1997cited by this paper
• Various hypertrophic stimuli induce distinct phenotypes in cardiomyocytes

  1997cited by this paper
• Cardiac compartment-specific overexpression of a modified retinoic acid receptor produces dilated cardiomyopathy and congestive heart failure in transgenic mice.

  1997cited by this paper
• Transgenic Galphaq overexpression induces cardiac contractile failure in mice.

  1997cited by this paper
• The MEKK-JNK Pathway Is Stimulated by α1-Adrenergic Receptor and Ras Activation and Is Associated with in Vitroand in Vivo Cardiac Hypertrophy*

  1997cited by this paper
• Myosin heavy chain gene expression in human heart failure.

  1997cited by this paper
• Studies on the function of Rho A protein in cardiac myofibrillogenesis

  1997cited by this paper
• Overexpression of angiotensin AT1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block.

  1997cited by this paper
• Rho is required for Galphaq and alpha1-adrenergic receptor signaling in cardiomyocytes. Dissociation of Ras and Rho pathways.

  1996cited by this paper
• Transthoracic echocardiography in models of cardiac disease in the mouse.

  1996cited by this paper
• Ablation of the murine alpha myosin heavy chain gene leads to dosage effects and functional deficits in the heart.

  1996cited by this paper
• Rho Is Required for Gαq and α1-Adrenergic Receptor Signaling in Cardiomyocytes

  1996cited by this paper
• Ventricular Expression of a MLC-2v-ras Fusion Gene Induces Cardiac Hypertrophy and Selective Diastolic Dysfunction in Transgenic Mice (*)

  1995influential reference
• Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy.

  1995cited by this paper
• Gq- and ras-dependent pathways mediate hypertrophy of neonatal rat ventricular myocytes following alpha 1-adrenergic stimulation.

  1994cited by this paper
• Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and nonfailing human myocardium.

  1994cited by this paper
• Ras activity is required for phenylephrine-induced activation of mitogen-activated protein kinase in cardiac muscle cells.

  1994cited by this paper
• Targeted developmental overexpression of calmodulin induces proliferative and hypertrophic growth of cardiomyocytes in transgenic mice.

  1993cited by this paper
• HRas-dependent pathways can activate morphological and genetic markers of cardiac muscle cell hypertrophy.

  1993cited by this paper
• Tyrosine kinase-dependent suppression of a potassium channel by the G protein-coupled m1 muscarinic acetylcholine receptor.

  1993cited by this paper
• Tissue-specific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice.

  1991cited by this paper
• Cloning and expression of a rat cardiac delayed rectifier potassium channel.

  1991cited by this paper
• Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response

  1991cited by this paper
• Altered sarcoplasmic reticulum Ca2(+)-ATPase gene expression in the human ventricle during end-stage heart failure.

  1990cited by this paper
• Ionic channels and their regulation by G protein subunits.

  1990cited by this paper

• Mechanosensitive biochemical imprinting of the talin interaction with DLC1 regulates RhoA activity and cardiomyocyte remodeling

  2025cites this paper
• Regulation of cardiomyocyte intracellular trafficking and signal transduction by protein palmitoylation

  2024cites this paper
• Bortezomib induces Rho-dependent hyperpermeability of endothelial cells synergistically with inflammatory mediators

  2024cites this paper
• Untangling the role of RhoA in the heart: protective effect and mechanism

  2024cites this paper
• PPP1R12C Promotes Atrial Hypocontractility in Atrial Fibrillation

  2023cites this paper
• An Alternative Mechanism of Subcellular Iron Uptake Deficiency in Cardiomyocytes

  2023cites this paper
• Overview of programmed electrical stimulation to assess atrial fibrillation susceptibility in mice

  2023cites this paper
• Palmitoylation-dependent regulation of cardiomyocyte Rac1 signaling activity and minor effects on cardiac hypertrophy

  2023cites this paper
• Myosin Light Chain Dephosphorylation by PPP1R12C Promotes Atrial Hypocontractility in Atrial Fibrillation

  2023cites this paper
• Atrioventricular node dysfunction in pressure overload-induced heart failure—Involvement of the immune system and transcriptomic remodelling

  2023cites this paper
• Cardiomyocyte mechanical memory is regulated through the talin interactome and DLC1 dependent regulation of RhoA

  2023cites this paper
• Inhibition of RhoA and Cdc42 by miR-133a Modulates Retinoic Acid Signalling during Early Development of Posterior Cardiac Tube Segment

  2022cites this paper
• Mouse models of spontaneous atrial fibrillation

  2022cites this paper
• PI3K(p110α) as a determinant and gene therapy for atrial enlargement in atrial fibrillation

  2022cites this paper
• Mass spectrometry-based proteomics in neurodegenerative lysosomal storage disorders.

  2022cites this paper
• Inhibition of β1-AR/Gαs signaling promotes cardiomyocyte proliferation in juvenile mice through activation of RhoA-YAP axis

  2022cites this paper
• Signaling Pathways Involved in Myocardial Ischemia–Reperfusion Injury and Cardioprotection: A Systematic Review of Transcriptomic Studies in Sus scrofa

  2022cites this paper
• RhoA/ROCK Signaling in Cardiac Pathophysiology RhoA/ROCK Signaling in Cardiac Pathophysiology

  2022cites this paper
• Cardiac decompensation and promiscuous prenylation of small GTPases in cardiomyocytes in response to local mevalonate pathway disruption†

  2021cites this paper
• Inhibition of adrenergic β1-AR/Gαs signaling promotes cardiomyocyte proliferation through activation of RhoA-YAP axis

  2021cites this paper
• Cardioprotective Role of Heat Shock Proteins in Atrial Fibrillation: From Mechanism of Action to Therapeutic and Diagnostic Target

  2021cites this paper
• S-Palmitoylation-Dependent Regulation of Cardiomyocyte Rac1 Signaling Activity and Cardiac Hypertrophy

  2021cites this paper
• Characteristic Effects of the Cardiac Non-Neuronal Acetylcholine System Augmentation on Brain Functions

  2021cites this paper
• Molecular Signaling to Preserve Mitochondrial Integrity against Ischemic Stress in the Heart: Rescue or Remove Mitochondria in Danger

  2021cites this paper
• RhoA: a dubious molecule in cardiac pathophysiology

  2021cites this paper
• Identification of Potential miRNA-mRNA Regulatory Network Contributing to Hypertrophic Cardiomyopathy (HCM)

  2021cites this paper
• Inhibition of the mevalonate pathway improves myocardial fibrosis

  2021cites this paper
• Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting.

  2020cites this paper
• Application quantitative proteomics approach to identify differentially expressed proteins associated with cardiac protection mediated by cycloastragenol in acute myocardial infarction rats.

  2020cites this paper
• Small G—protein RhoA is a potential inhibitor of cardiac fast sodium current

  2020cites this paper
• RhoGTPase in Vascular Disease

  2019cites this paper
• Involvement of PI3K, Akt and RhoA in Oestradiol Regulation of Cardiac iNOS Expression.

  2019cites this paper
• Protective transcriptional mechanisms in cardiomyocytes and cardiac fibroblasts.

  2019cites this paper
• HDAC (Histone Deacetylase) Inhibitor Valproic Acid Attenuates Atrial Remodeling and Delays the Onset of Atrial Fibrillation in Mice

  2019cites this paper
• Desmoglein 2 mutation provokes skeletal muscle actin expression and accumulation at intercalated discs in murine hearts

  2019cites this paper
• Generation of GLA-Knockout Human Embryonic Stem Cell Lines to Model Autophagic Dysfunction and Exosome Secretion in Fabry Disease-Associated Hypertrophic Cardiomyopathy

  2019cites this paper
• Analysis of the GPCR-induced RhoA signaling in healthy and diseased adult cardiomyocytes

  2019cites this paper
• Network-based predictions of in vivo cardiac hypertrophy.

  2018cites this paper
• Disruption of RHOA‐ROCK Signaling Results in Atrioventricular Block and Disturbed Development of the Putative Atrioventricular Node

  2018cites this paper
• Systems Genetics Approaches in Rat Identify Novel Genes and Gene Networks Associated With Cardiac Conduction

  2018cites this paper
• Chapter 4 Kinomic array analysis identifies Akt and CDK 4 as druggable kinases limiting Atrial Fibrillation remodeling

  2018cites this paper
• Amendment history : Erratum ( May 2003 ) Genotype , phenotype : upstairs , downstairs in the family of cardiomyopathies

  2018cites this paper
• Crucial Role of ROCK2-Mediated Phosphorylation and Upregulation of FHOD3 in the Pathogenesis of Angiotensin II–Induced Cardiac Hypertrophy

  2017cites this paper
• Murine Electrophysiological Models of Cardiac Arrhythmogenesis.

  2017cites this paper
• Z-disc protein CHAPb induces cardiomyopathy and contractile dysfunction in the postnatal heart

  2017cites this paper
• Cardiac Fibrosis and Arrhythmogenesis.

  2017cites this paper
• RHOA-ROCK signalling is necessary for lateralization and differentiation of the developing sinoatrial node

  2017cites this paper
• Crucial Role of ROCK 2-Mediated Phosphorylation and Upregulation of FHOD 3 in the Pathogenesis of Angiotensin II – Induced Cardiac Hypertrophy

  2017cites this paper
• Rho-kinase inhibition reverses impaired Ca2+ handling and associated left ventricular dysfunction in pressure overload-induced cardiac hypertrophy.

  2017cites this paper
• Cardiac rhythm and pacemaking abnormalities in patients affected by endemic pemphigus in Colombia may be the result of deposition of autoantibodies, complement, fibrinogen, and other molecules.

  2017cites this paper
• A GAL4‐inducible transgenic tool kit for the in vivo modulation of Rho GTPase activity in zebrafish

  2016cites this paper
• The Role of the Rho/ROCK Pathway in Ang II and TGF-β1-Induced Atrial Remodeling

  2016cites this paper
• Signaling Pathways in Cardiac Myocyte Apoptosis

  2016cites this paper
• Implications of the cardiomyocyte stress response on protein homeostasis in atrial fibrillation

  2016cites this paper
• Alteration of RhoA Prenylation Ameliorates Cardiac and Vascular Remodeling in Spontaneously Hypertensive Rats

  2016cites this paper
• Oligophrenin1 protects mice against myocardial ischemia and reperfusion injury by modulating inflammation and myocardial apoptosis.

  2016cites this paper
• Fn14 is regulated via the RhoA pathway and mediates nuclear factor-kappaB activation by Angiotensin II.

  2016cites this paper
• Erratum: CAP2 in cardiac conduction, sudden cardiac death and eye development

  2016cites this paper
• RhoGTPases and their relevance for the afterload-dependent myocardial fibrosis

  2016cites this paper
• Rho Kinases and Cardiac Remodeling.

  2016cites this paper
• The avian embryo to study development of the cardiac conduction system.

  2016cites this paper
• Effect of siRNA silencing of inducible co-stimulatory molecule on myocardial cell hypertrophy after cardiac infarction in rats.

  2016cites this paper
• Implications of the cardiomyocyte stress response on protein homeostasis in atrial fibrillation

  2016cites this paper
• Implications of the cardiomyocyte stress response on protein homeostasis in atrial fibrillation

  2016cites this paper
• Implications of the cardiomyocyte stress response on protein homeostasis in atrial fibrillation

  2016cites this paper
• Implications of the cardiomyocyte stress response on protein homeostasis in atrial fibrillation

  2016cites this paper
• Implications of the cardiomyocyte stress response on protein homeostasis in atrial fibrillation

  2016cites this paper
• Targeting proteostasis in atrial fibrillation

  2015cites this paper
• Long-Term Overexpression of Hsp70 Does Not Protect against Cardiac Dysfunction and Adverse Remodeling in a MURC Transgenic Mouse Model with Chronic Heart Failure and Atrial Fibrillation

  2015cites this paper
• RhoA activity increased in myocardium of arrhythmogenic cardiomyopathy patients and affected connexin 43 protein expression in HL-1 cells.

  2015cites this paper
• The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb–mTORC1 signalling and leads to chronic heart failure

  2015cites this paper
• University of Groningen RhoA Activation Sensitizes Cells to Proteotoxic Stimuli by Abrogating the HSF 1-Dependent Heat Shock

  2015cites this paper
• LKB1 Knockout Mouse Develops Spontaneous Atrial Fibrillation and Provides Mechanistic Insights Into Human Disease Process

  2015cites this paper
• RhoA Activation Sensitizes Cells to Proteotoxic Stimuli by Abrogating the HSF1-Dependent Heat Shock Response

  2015cites this paper
• Diagnosis and Therapy of Atrial Fibrillation: The Past, The Present and The Future.

  2015cites this paper
• Norepinephrine-Induced Adrenergic Activation Strikingly Increased the Atrial Fibrillation Duration through β1- and α1-Adrenergic Receptor-Mediated Signaling in Mice

  2015cites this paper
• CAP2 in cardiac conduction, sudden cardiac death and eye development

  2015cites this paper
• Substance P Receptor Antagonism: A Potential Novel Treatment Option for Viral-Myocarditis

  2015cites this paper
• Animal Models of Cardiovascular Disease

  2015cites this paper
• Atrial fibrillation: mechanisms, therapeutics, and future directions.

  2015cites this paper
• RhoA signaling in cardiomyocytes protects against stress-induced heart failure but facilitates cardiac fibrosis

  2014cites this paper
• Loss of proteostasis as a substrate for atrial fibrillation

  2014cites this paper
• The good, the bad, and the ugly

  2014cites this paper
• Induction of Atrial Fibrillation by Neutrophils Critically Depends on CD11b/CD18 Integrins

  2014cites this paper
• Cardiac arrhythmia induced by genetic silencing of “funny” (f) channels is rescued by GIRK4 inactivation

  2014cites this paper
• Inhibition of farnesyl pyrophosphate synthase prevents angiotensin II‐induced cardiac fibrosis in vitro

  2014cites this paper
• Long-term administration of rosuvastatin prevents contractile and electrical remodelling of diabetic rat heart

  2013cites this paper
• Z-disc protein CHAPb induces cardiomyopathy and diastolic dysfunction

  2013cites this paper
• Rodent models of heart failure: an updated review

  2013cites this paper
• Cardiac-specific overexpression of farnesyl pyrophosphate synthase induces cardiac hypertrophy and dysfunction in mice.

  2013cites this paper
• Role of Small GTPase Protein Rac1 in Cardiovascular Diseases: Development of New Selective Pharmacological Inhibitors

  2013cites this paper
• Rodent models of heart failure: an updated review

  2013cites this paper
• Role of Rac1–mineralocorticoid-receptor signalling in renal and cardiac disease

  2013cites this paper
• Inhibition of farnesyl pyrophosphate synthase attenuates angiotensin II-induced cardiac hypertrophy and fibrosis in vivo.

  2013cites this paper
• Tranilast prevents atrial remodeling and development of atrial fibrillation in a canine model of atrial tachycardia and left ventricular dysfunction.

  2013cites this paper
• Small G proteins in the cardiovascular system: physiological and pathological aspects.

  2013cites this paper
• G13-Mediated Signaling Pathway Is Required for Pressure Overload–Induced Cardiac Remodeling and Heart Failure

  2012cites this paper
• An Introduction to Murine Models of Atrial Fibrillation

  2012influential citation
• Neurocardiac dysregulation and neurogenic arrhythmias in a transgenic mouse model of Huntington's disease

  2012cites this paper
• A Novel Transgenic Mouse Model of Cardiac Hypertrophy and Atrial Fibrillation.

  2012cites this paper